- Release Date: 13/09/22 09:12
- Summary: Rett Syndrome NDA accepted for Priority Review by FDA
- Price Sensitive: Yes
- Download Document 231.46KB
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
-
- There are more pages in this discussion • 163 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.10 |
Change
-0.255(2.06%) |
Mkt cap ! $1.545B | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.20 | $12.02 | $1.276M | 105.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 453 | $12.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.10 | 422 | 9 |
View Market Depth
| Last trade - 13.09pm 01/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |